by Christian Lienhardt, Karin Weyer, Dennis Falzon et al.
World Health Organization, 2013
WHO Member States have requested the organization to provide interim policy guidance on the use of bedaquiline as part of the treatment of multidrug-resistant tuberculosis (MDR-TB). This document provides interim guidance for the use of bedaquiline in conjunction with other WHO-recommended MDR-TB treatments. It also specifies the essential treatment and management conditions for the use of this drug.